Lack of complement factor C3, but not factor B, increases hyperlipidemia and atherosclerosis in apolipoprotein E-/- low-density lipoprotein receptor-/- mice

被引:85
作者
Persson, L
Borén, J
Robertson, AKL
Wallenius, V
Hansson, GK
Pekna, M
机构
[1] Univ Gothenburg, Sahlgrenska Acad, Dept Med Biochem, S-40530 Gothenburg, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Wallenberg Lab Cardiovasc Res, S-40530 Gothenburg, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Res Ctr Endocrinol & Metab, S-40530 Gothenburg, Sweden
[4] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden
关键词
atherosclerosis; complement; C3; factor B; hyperlipidemia;
D O I
10.1161/01.ATV.0000127302.24266.40
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - To investigate the effect of complement deficiency on atherogenesis and lipidemia, we used mice deficient in the third complement component (C3-/-) or factor B (FB-/-). Methods and Results - Complement-deficient mice were crossed with mice deficient in both apolipoprotein E and the low-density lipoprotein receptor (Apoe-/- LDLR-/-). The percent lesion area in the aorta at 16 weeks, determined by en face analysis, was 84% higher in C3-/- mice than in controls (11.8% +/- 0.4% versus 6.4% +/- 0.8%, mean +/- SEM, P < 0.00005). The C3-/- mice also had 58% higher serum triglyceride levels (P < 0.05) and a more proatherogenic lipoprotein profile, with significantly more low-density lipoprotein cholesterol and very-low-density lipoprotein triglycerides than control mice. The C3-/- mice weighed 13% less (P < 0.01) and had a lower body fat content (3.5% +/- 1.0% versus 13.1% +/- 3.0%, P < 0.01). There were no differences between FB-/- mice and controls. Conclusions - Complement activation by the classical or lectin pathway exerts atheroprotective effects, possibly through the regulation of lipid metabolism.
引用
收藏
页码:1062 / 1067
页数:6
相关论文
共 50 条
  • [31] Effect of trans-resveratrol on the thrombogenicity and atherogenicity in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice
    Fukao, H
    Ijiri, Y
    Miura, M
    Hashimoto, M
    Yamashita, T
    Fukunaga, C
    Oiwa, K
    Kawai, Y
    Suwa, M
    Yamamoto, J
    BLOOD COAGULATION & FIBRINOLYSIS, 2004, 15 (06) : 441 - 446
  • [32] Antiatherosclerotic Effects of 1-Methylnicotinamide in Apolipoprotein E/Low-Density Lipoprotein Receptor-Deficient Mice: A Comparison with Nicotinic Acid
    Mateuszuk, Lukasz
    Jasztal, Agnieszka
    Maslak, Edyta
    Gasior-Glogowska, Marlena
    Baranska, Malgorzata
    Sitek, Barbara
    Kostogrys, Renata
    Zakrzewska, Agnieszka
    Kij, Agnieszka
    Walczak, Maria
    Chlopicki, Stefan
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 356 (02) : 514 - 524
  • [33] Resveratrol protects against diet-induced atherosclerosis by reducing low-density lipoprotein cholesterol and inhibiting inflammation in apolipoprotein E-deficient mice
    Chang, Geng-Ruei
    Chen, Po-Lin
    Hou, Po-Hsun
    Mao, Frank Chiahung
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2015, 18 (11) : 1063 - 1071
  • [34] Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice
    von der Thüsen, JH
    van Berkel, TJC
    Biessen, EAL
    CIRCULATION, 2001, 103 (08) : 1164 - 1170
  • [35] p55 Tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice
    Xanthoulea, Sofia
    Gijbels, Marion J. J.
    van der Made, Ingeborg
    Mujcic, Hilda
    Thelen, Melanie
    Vergouwe, Monique N.
    Ambagts, Matheus H. C.
    Hofker, Marten H.
    de Winther, Menno P. J.
    CARDIOVASCULAR RESEARCH, 2008, 80 (02) : 309 - 318
  • [36] Transforming growth factor-β1 increases the expression of lectin-like oxidized low-density lipoprotein receptor-1
    Minami, M
    Kume, N
    Kataoka, H
    Morimoto, M
    Hayashida, K
    Sawamura, T
    Masaki, T
    Kita, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 272 (02) : 357 - 361
  • [37] Cosegregation of Aortic Root Atherosclerosis and Intermediate Lipid Phenotypes on Chromosomes 2 and 8 in an Intercross of C57BL/6 and BALBc/ByJ Low-Density Lipoprotein Receptor-/- Mice
    Burkhardt, Ralph
    Suendermann, Simon
    Ludwig, Doris
    Ceglarek, Uta
    Holdt, Lesca M.
    Thiery, Joachim
    Teupser, Daniel
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (04) : 775 - U143
  • [38] Apolipoprotein E Mediates Enhanced Plasma High-Density Lipoprotein Cholesterol Clearance by Low-Dose Streptococcal Serum Opacity Factor via Hepatic Low-Density Lipoprotein Receptors In Vivo
    Rosales, Corina
    Tang, Daming
    Gillard, Baiba K.
    Courtney, Harry S.
    Pownall, Henry J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (08) : 1834 - U292
  • [39] TRANSFORMING GROWTH-FACTOR-BETA MODULATES C3 AND FACTOR-B BIOSYNTHESIS AND COMPLEMENT RECEPTOR-3 EXPRESSION IN CULTURED HUMAN MONOCYTES
    HOGASEN, AKM
    HESTDAL, K
    HOGASEN, K
    ABRAHAMSEN, TG
    JOURNAL OF LEUKOCYTE BIOLOGY, 1995, 57 (02) : 287 - 296
  • [40] Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages
    Koga, Mitsuhisa
    Inada, Koshun
    Yamada, Ayano
    Maruoka, Kana
    Yamauchi, Atsushi
    BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2024, 38